Churg–Strauss syndrome
Abstract Churg–Strauss syndrome (CSS), alternatively known as eosinophilic
granulomatosis with polyangiitis (EGPA), was first described in 1951 by Churg and Strauss …
granulomatosis with polyangiitis (EGPA), was first described in 1951 by Churg and Strauss …
Eosinophilic granulomatosis with polyangiitis: clinical pathology conference and review
EY Wu, ML Hernandez, JC Jennette, RJ Falk - The Journal of Allergy and …, 2018 - Elsevier
Eosinophilic granulomatosis with polyangiitis (EGPA)(formerly Churg-Strauss syndrome) is
a small vessel vasculitis associated with asthma and eosinophilia. Despite its rarity …
a small vessel vasculitis associated with asthma and eosinophilia. Despite its rarity …
FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review
Objectives We aimed to assess the clinical value of FDG-PET/CT in patients with ANCA-
associated vasculitis. Materials and methods We retrospectively included 16 patients with …
associated vasculitis. Materials and methods We retrospectively included 16 patients with …
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
P Faverio, G Bonaiti, F Bini, A Vaghi… - Therapeutics and Clinical …, 2018 - Taylor & Francis
Mepolizumab is an anti-interleukin-5 (IL-5) humanized monoclonal antibody that binds to
free IL-5. It induces bone marrow eosinophil maturation arrest and decreases eosinophil …
free IL-5. It induces bone marrow eosinophil maturation arrest and decreases eosinophil …
Eosinophilic vasculitis
KL Vega Villanueva, LR Espinoza - Current Rheumatology Reports, 2020 - Springer
Abstract Purpose of Review Eosinophilic granulomatosis with polyangiitis (EGPA)
represents a rare clinical entity, which is getting increasing attention and relevance in view …
represents a rare clinical entity, which is getting increasing attention and relevance in view …
[HTML][HTML] Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
F Menzella, C Galeone, G Ghidoni… - Multidisciplinary …, 2021 - ncbi.nlm.nih.gov
Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with
polyangiitis refractory to mepolizumab - PMC Back to Top Skip to main content NIH NLM Logo …
polyangiitis refractory to mepolizumab - PMC Back to Top Skip to main content NIH NLM Logo …
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis
D Ennis, JK Lee, C Pagnoux - Expert Opinion on Biological …, 2019 - Taylor & Francis
Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare antineutrophil
cytoplasmic antibody (ANCA)-associated vasculitis characterized by asthma …
cytoplasmic antibody (ANCA)-associated vasculitis characterized by asthma …
[HTML][HTML] Development of a certified reference material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)
E Monogioudi, DP Hutu, G Martos, J Sheldon… - Clinica Chimica …, 2017 - Elsevier
Abstract A serum Certified Reference Material (CRM) for supporting reliable autoimmune
diagnostics was recently released by the Institute for Reference Materials and …
diagnostics was recently released by the Institute for Reference Materials and …
Pulmonary vasculature and critical asthma syndromes: a comprehensive review
M Avdalovic - Clinical reviews in allergy & immunology, 2015 - Springer
One of the important factors and consequences in persistent asthma is the change in the
vasculature of the airways and lung parenchyma. These changes could contribute to …
vasculature of the airways and lung parenchyma. These changes could contribute to …
[HTML][HTML] Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
G Venade, C Figueiredo, C Almeida… - Revista da Associação …, 2020 - SciELO Brasil
SUMMARY Churg–Strauss syndrome, Eosinophilic granulomatosis with polyangiitis
(EGPA), is a systemic vasculitis that affects small–to medium-sized vessels. It is rare and part …
(EGPA), is a systemic vasculitis that affects small–to medium-sized vessels. It is rare and part …